Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Danner

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
The Journal of Infectious Diseases|June 1, 1995
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)R Schuurman, M Nijhuis, R van Leeuwen, et al.
AIDS (London, England)|September 13, 2000
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudineE H Gisolf, R H Enting, S Jurriaans, et al.
Lancet (London, England)|February 3, 1990
Foscarnet and penile ulcerationJ W Van Der Pijl, P H Frissen, P Reiss, et al.
Archives of Internal Medicine|January 1, 1988
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control studyJ K Eeftinck Schattenkerk, S A Danner, J M Lange, et al.
The New England Journal of Medicine|May 10, 1990
Failure of zidovudine prophylaxis after accidental exposure to HIV-1J M Lange, C A Boucher, C E Hollak, et al.
Antiviral Research|March 13, 1998
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infectionsM D de Jong, C A Boucher, S A Danner, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
AIDS (London, England)|April 1, 1995
Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosaF Snijders, S J van Deventer, J F Bartelsman, et al.
The Netherlands Journal of Medicine|April 1, 1989
Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virusM T Roos, F Miedema, J K Eeftinck Schattenkerk, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
The Journal of Infectious Diseases|June 1, 1995
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)R Schuurman, M Nijhuis, R van Leeuwen, et al.
AIDS (London, England)|September 13, 2000
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudineE H Gisolf, R H Enting, S Jurriaans, et al.
Lancet (London, England)|February 3, 1990
Foscarnet and penile ulcerationJ W Van Der Pijl, P H Frissen, P Reiss, et al.
Archives of Internal Medicine|January 1, 1988
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control studyJ K Eeftinck Schattenkerk, S A Danner, J M Lange, et al.
The New England Journal of Medicine|May 10, 1990
Failure of zidovudine prophylaxis after accidental exposure to HIV-1J M Lange, C A Boucher, C E Hollak, et al.
Antiviral Research|March 13, 1998
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infectionsM D de Jong, C A Boucher, S A Danner, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
AIDS (London, England)|April 1, 1995
Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosaF Snijders, S J van Deventer, J F Bartelsman, et al.
The Netherlands Journal of Medicine|April 1, 1989
Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virusM T Roos, F Miedema, J K Eeftinck Schattenkerk, et al.
Pageof 15